BioSig Technologies, Inc. (BSGM)

USD 1.28

(-3.76%)

Market Cap (In USD)

22.06 Million

Revenue (In USD)

18 Thousand

Net Income (In USD)

-29.04 Million

Avg. Volume

24.1 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.201-5.0
PE
-
EPS
-
Beta Value
0.353
ISIN
US09073N3008
CUSIP
09073N201
CIK
1530766
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Anthony Amato
Employee Count
-
Website
https://www.biosig.com
Ipo Date
2014-10-31
Details
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.